Fairvoy Private Wealth LLC Buys New Holdings in Cigna Group $CI

Fairvoy Private Wealth LLC bought a new stake in shares of Cigna Group (NYSE:CIFree Report) during the second quarter, Holdings Channel reports. The fund bought 765 shares of the health services provider’s stock, valued at approximately $253,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in CI. Brighton Jones LLC lifted its position in shares of Cigna Group by 9.3% during the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after buying an additional 318 shares in the last quarter. NBC Securities Inc. purchased a new position in shares of Cigna Group during the 1st quarter valued at approximately $123,000. Merit Financial Group LLC lifted its position in shares of Cigna Group by 135.7% during the 1st quarter. Merit Financial Group LLC now owns 5,498 shares of the health services provider’s stock valued at $1,809,000 after buying an additional 3,165 shares in the last quarter. RFG Advisory LLC purchased a new position in shares of Cigna Group during the 1st quarter valued at approximately $233,000. Finally, Hennion & Walsh Asset Management Inc. lifted its position in shares of Cigna Group by 13.5% during the 1st quarter. Hennion & Walsh Asset Management Inc. now owns 1,212 shares of the health services provider’s stock valued at $399,000 after buying an additional 144 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on CI shares. Royal Bank Of Canada reissued an “outperform” rating and issued a $371.00 price objective on shares of Cigna Group in a research note on Thursday, June 26th. Cantor Fitzgerald reissued an “overweight” rating and issued a $365.00 price objective on shares of Cigna Group in a research note on Tuesday, August 26th. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on Cigna Group and gave the company a “buy” rating in a research note on Tuesday, August 5th. TD Cowen raised Cigna Group to a “strong-buy” rating in a research note on Monday, June 23rd. Finally, Guggenheim reissued a “buy” rating and issued a $350.00 price objective (down from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $371.81.

Check Out Our Latest Stock Analysis on CI

Insider Transactions at Cigna Group

In other news, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.70% of the stock is owned by corporate insiders.

Cigna Group Stock Performance

NYSE CI opened at $311.24 on Friday. The stock has a market cap of $83.08 billion, a PE ratio of 16.99, a P/E/G ratio of 0.87 and a beta of 0.45. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a twelve month low of $256.89 and a twelve month high of $358.88. The stock has a fifty day simple moving average of $292.41 and a 200-day simple moving average of $309.81.

Cigna Group (NYSE:CIGet Free Report) last announced its earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company had revenue of $67.13 billion during the quarter, compared to analysts’ expectations of $62.61 billion. During the same period last year, the business posted $6.72 EPS. Cigna Group’s revenue for the quarter was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were given a $1.51 dividend. The ex-dividend date of this dividend was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a yield of 1.9%. Cigna Group’s dividend payout ratio (DPR) is currently 32.97%.

About Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.